Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study
Schrijver,L.H., Antoniou,A.C., Olsson,H., Mooij,T.M., Roos-Blom,M.J., Azarang,L., Adlard,J., Ahmed,M., Barrowdale,D., Davidson,R., Donaldson,A., Eeles,R., Evans,D.G., Frost,D., Henderson,A., Izatt,L., Ong,K.R., Bonadona,V., Coupier,I., Faivre,L., Fricker,J.P., Gesta,P., van Engelen,K., Jager,A., Menko,F.H., Mourits,M.J.E., Singer,C.F., Tan,Y.Y., Foretova,L., Navratilova,M., Schmutzler,R.K., Ellberg,C., Gerdes,A.M., Caldes,T., Simard,J., Olah,E., Jakubowska,A., Rantala,J., Osorio,A., Hopper,J.L., Phillips,K.A., Milne,R.L., Terry,M.B., Nogues,C., Engel,C., Kast,K., Goldgar,D.E., Leeuwen,F.E.V., Easton,D.F., Andrieu,N., Rookus,M.A., EMBRACE, GENEPSO, HEBON and IBCCS
2021 /
1
Volume : 225
Pages : 51.e1-51.e17